Finance

Lists
PYC:ASX
PYC Therapeutics Ltd
A$2.79
+4.49%
(+0.12) 1D
Sep 21, 4:10:31 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for PYC...
Open
A$2.58
High
A$2.93
Low
A$2.58
Mkt. cap
2.74B
Avg. vol.
4.67M
Volume
8.16M
52-wk high
A$2.93
52-wk low
A$0.96
EPS
-A$0.06
Shares outstanding
983.51M
No. of employees
23
Open
A$2.58
High
A$2.93
Low
A$2.58
Mkt. cap
2.74B
Avg. vol.
4.67M
Volume
8.16M
52-wk high
A$2.93
52-wk low
A$0.96
EPS
-A$0.06
Shares outstanding
983.51M
No. of employees
23
News stories
From web sources and news partners
About PYC Therapeutics Ltd
CEORohan Hockings
Employees23
Founded2001
Headquarters-
SectorBiotechnology
Websitepyctx.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
4.45M
4.45M
8.55M
8.55M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
15.35M
15.35M
21.64M
21.64M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.71M
1.71M
3.00M
3.00M
Operating expense
17.07M
17.07M
24.63M
24.63M
Total operating expenses
17.07M
17.07M
24.63M
24.63M
Operating income
-12.62M
-12.62M
-16.09M
-16.09M
Other non operating income
-
-
-
-
EBT including unusual items
-11.56M
-11.56M
-10.32M
-10.32M
EBT excluding unusual items
-11.56M
-11.56M
-10.32M
-10.32M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-11.41M
-11.41M
-10.26M
-10.26M
Net profit margin
-256.44%
-256.44%
-120.01%
-120.01%
Earnings per share
-
-
-
-
Interest and investment income
1.07M
1.07M
5.77M
5.77M
Interest expense
-11.85K
-11.85K
-8.38K
-8.38K
Net interest expenses
1.06M
1.06M
5.76M
5.76M
Depreciation and amortization charges
-
-
-
-
EBITDA
-12.47M
-12.47M
-15.83M
-15.83M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps